デフォルト表紙
市場調査レポート
商品コード
1615376

フシジン酸市場:純度、投与、最終製品、用途、最終用途別-2025~2030年の世界予測

Fusidic Acid Market by Purity (97% to 99%, Above 99%, Below 97%), Administration (Intravenous, Oral, Topical), End-Product, Application, End-Use - Global Forecast 2025-2030


出版日
発行
360iResearch
ページ情報
英文 190 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
フシジン酸市場:純度、投与、最終製品、用途、最終用途別-2025~2030年の世界予測
出版日: 2024年12月01日
発行: 360iResearch
ページ情報: 英文 190 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

フシジン酸市場は、2023年に1億7,366万米ドルと評価され、2024年には1億8,149万米ドルに達すると予測され、CAGR 4.59%で成長し、2030年には2億3,786万米ドルに達すると予測されています。

フシジン酸は主に細菌感染症、特に膿痂疹や蜂窩織炎のような皮膚感染症の治療に使用される抗生物質です。市場範囲は、主に医薬品セグメントでの応用を包含しており、外用クリーム、軟膏、点眼薬に組み込まれています。フシジン酸の必要性は、黄色ブドウ球菌のようなグラム陽性菌に対する有効性から生まれ、抗生物質耐性感染症に対処する上で極めて重要です。その最終用途は主に病院、クリニック、外来患者であり、そこでは効果的な局所治療の需要が高いです。この市場に影響を与える主要成長要因としては、皮膚感染症の罹患率の上昇、抗生物質耐性に対する意識の高まり、新興市場における医療産業の拡大などが挙げられます。耐性株に対する有効性を高めるための併用療法や、比較的未開拓である動物用医薬品への応用の可能性に関する研究が急増していることから、新たなビジネス機会が生まれる可能性があります。利害関係者への提言としては、新規製剤を革新するための研究開発への投資や、新興国市場での市場開拓のためのパートナーシップの模索などが挙げられます。

主要市場の統計
基準年[2023年] 1億7,366万米ドル
推定年[2024年] 1億8,149万米ドル
予測年[2030年] 2億3,786万米ドル
CAGR(%) 4.59%

市場成長を阻害する課題には、医薬品認可のための厳しい規制要件、潜在的な副作用、使用量減少につながる可能性のある抗生物質耐性に対する懸念の高まりなどがあります。また、代替抗生物質との競合や、自然療法やハーブ療法への傾向の高まりも抑制要因となっています。こうした課題にもかかわらず、技術革新の可能性を秘めたセグメントとしては、ナノ技術を駆使したソリューションなど、新しいドラッグデリバリーシステムの開発や、皮膚科領域だけでなく、呼吸器や眼科領域への応用の可能性を探ることなどが挙げられます。競合市場の競争は依然として緩やかで、強固な世界流通網の確立を目指した統合市場戦略の機会があります。市場力学が進化を続ける中、医療研究と技術の進歩に常に敏感であることは、成長機会を獲得し競合を維持する上で極めて重要です。

市場力学:急速に進化するフシジン酸市場の主要市場洞察を公開

フシジン酸市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

  • 市場促進要因
    • 世界の皮膚感染症患者数の増加
    • 特に病院環境におけるMRSA感染の増加
    • 医療と製薬部門における継続的な研究開発イニシアティブと研究費
  • 市場抑制要因
    • 新たな抗生物質や代替治療法の出現
  • 市場機会
    • フシジン酸の有効性を高める併用治療の開発
    • フシジン酸の皮膚疾患以外の微生物感染症治療への多様な応用の出現
  • 市場課題
    • フシジン酸の有効性を脅かす抗生物質耐性株の急増

ポーターのファイブフォース:フシジン酸市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、フシジン酸市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析:フシジン酸市場における外部からの影響の把握

外部マクロ環境要因は、フシジン酸市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析:フシジン酸市場における競合情勢の把握

フシジン酸市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス:フシジン酸市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、フシジン酸市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨:フシジン酸市場における成功への道筋を描く

フシジン酸市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度:現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度:新興市場における成長機会を特定し、既存セグメントにおける拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化:最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報:競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション:将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は?

2.最高の投資機会を提供する製品、地域はどこか?

3.市場を形成する主要技術動向と規制の影響とは?

4.主要ベンダーの市場シェアと競合ポジションは?

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で皮膚感染症の症例が増加
      • 特に病院でのMRSA感染の増加
      • 医療と製薬セグメントにおける進行中の研究開発イニシアチブと調査費
    • 抑制要因
      • 新しい抗生物質と代替治療法の出現
    • 機会
      • 製品の効能を高めるためのフシジン酸との併用療法の開発
      • 皮膚疾患以外の微生物感染症の治療におけるフシジン酸の多様な応用の出現
    • 課題
      • 抗生物質耐性菌の急増により、フシジン酸の有効性に大きな脅威がもたらされている
  • 市場セグメンテーション分析
    • 投与:重篤な患者に対するフシジン酸の静脈内投与の意義
    • 用途:皮膚感染症の治療におけるフシジン酸の好感度が増加
  • ポーターのファイブフォース分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 法律
    • 環境

第6章 フシジン酸市場:純度別

  • イントロダクション
  • 97~99%
  • 99%以上
  • 97%以下

第7章 フシジン酸市場:投与別

  • イントロダクション
  • 静脈内
  • 経口
  • 局所

第8章 フシジン酸市場:最終製品別

  • イントロダクション
  • クリーム
  • 軟膏
  • 懸濁液
  • 錠剤

第9章 フシジン酸市場:用途別

  • イントロダクション
  • 併用療法
  • 眼感染症
  • 皮膚感染症
  • 全身感染症

第10章 フシジン酸市場:最終用途別

  • イントロダクション
  • 医療施設
  • 獣医クリニック

第11章 南北アメリカのフシジン酸市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋のフシジン酸市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカのフシジン酸市場

  • イントロダクション
  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析、2023年
  • FPNVポジショニングマトリックス、2023年
  • 競合シナリオ分析
    • 抗生物質の革新がスーパーバグとの戦いに役立つ
    • AMR Action Fundがスイスの抗生物質メーカーに投資
  • 戦略分析と提言

企業一覧

  • A.S. Lifesciences
  • Abigail Healthcare Pharmaceutical
  • Albert David Ltd.
  • Alvogen
  • Anant Pharmaceuticals Pvt. Ltd.
  • Azelis
  • B Joshi Agrochem Pharma Pvt. Ltd.
  • Easton Biopharmaceuticals
  • Eercros S.A.
  • Glasier Wellness Inc.
  • Glenmark Pharmaceuticals
  • Joyang Laboratories
  • Leo Pharma
  • Merck KGaA
  • Mylan N.V.
  • National Analytical Corporation
  • Oaknet Healthcare Pvt. Ltd. by Eris Lifesciences Limited
  • Otto Chemie Pvt. Ltd.
  • Taj Pharmaceuticals Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • TOKU-E
  • Wellona Pharma
  • Wuhan Dongkangyuan Technology Co., Ltd.
図表

LIST OF FIGURES

  • FIGURE 1. FUSIDIC ACID MARKET RESEARCH PROCESS
  • FIGURE 2. FUSIDIC ACID MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL FUSIDIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL FUSIDIC ACID MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL FUSIDIC ACID MARKET SIZE, BY PURITY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL FUSIDIC ACID MARKET SIZE, BY PURITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL FUSIDIC ACID MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL FUSIDIC ACID MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES FUSIDIC ACID MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES FUSIDIC ACID MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. FUSIDIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. FUSIDIC ACID MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. FUSIDIC ACID MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL FUSIDIC ACID MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL FUSIDIC ACID MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. FUSIDIC ACID MARKET DYNAMICS
  • TABLE 7. GLOBAL FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL FUSIDIC ACID MARKET SIZE, BY 97% TO 99%, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL FUSIDIC ACID MARKET SIZE, BY ABOVE 99%, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL FUSIDIC ACID MARKET SIZE, BY BELOW 97%, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL FUSIDIC ACID MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL FUSIDIC ACID MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL FUSIDIC ACID MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL FUSIDIC ACID MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL FUSIDIC ACID MARKET SIZE, BY OINTMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL FUSIDIC ACID MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL FUSIDIC ACID MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL FUSIDIC ACID MARKET SIZE, BY COMBINATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL FUSIDIC ACID MARKET SIZE, BY EYE INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL FUSIDIC ACID MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL FUSIDIC ACID MARKET SIZE, BY SYSTEMIC INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL FUSIDIC ACID MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL FUSIDIC ACID MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES FUSIDIC ACID MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA FUSIDIC ACID MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM FUSIDIC ACID MARKET SIZE, BY PURITY, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM FUSIDIC ACID MARKET SIZE, BY ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM FUSIDIC ACID MARKET SIZE, BY END-PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM FUSIDIC ACID MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM FUSIDIC ACID MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 237. FUSIDIC ACID MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. FUSIDIC ACID MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-F97DD5A7DAC4

The Fusidic Acid Market was valued at USD 173.66 million in 2023, expected to reach USD 181.49 million in 2024, and is projected to grow at a CAGR of 4.59%, to USD 237.86 million by 2030.

Fusidic Acid is primarily an antibiotic used for treating bacterial infections, especially skin infections like impetigo and cellulitis. The market scope encompasses its application primarily in the pharmaceutical sector, where it is integrated into topical creams, ointments, and eye drops. The necessity of Fusidic Acid emerges from its effectiveness against Gram-positive bacteria, such as Staphylococcus aureus, making it crucial for addressing antibiotic-resistant infections. Its end-use scope predominantly lies in hospitals, clinics, and outpatient care settings, where there is a high demand for effective topical treatments. Key growth factors influencing this market include the rising incidence of skin infections, increasing awareness about antibiotic resistance, and the expanding healthcare industry in emerging markets. Novel opportunities may arise from the burgeoning research into its use in combination therapies to enhance efficacy against resistant strains and its potential in veterinary applications, which remain relatively untapped. Recommendations for stakeholders include investing in R&D to innovate novel formulations and exploring partnerships for market penetration in developing regions.

KEY MARKET STATISTICS
Base Year [2023] USD 173.66 million
Estimated Year [2024] USD 181.49 million
Forecast Year [2030] USD 237.86 million
CAGR (%) 4.59%

Challenging factors hindering market growth include stringent regulatory requirements for drug approval, potential side effects, and the growing concern over antibiotic resistance that could lead to reduced usage. Limitations also stem from competition from alternative antibiotics and the rising trend towards natural and herbal remedies. Despite these challenges, areas rich in potential for innovation include developing new drug delivery systems, such as nanotechnology-based solutions, and exploring its applications beyond dermatology, possibly into respiratory and ophthalmic conditions. The nature of the Fusidic Acid market remains moderately competitive, with opportunities for integrated market strategies aimed at establishing robust global distribution networks. As market dynamics continue to evolve, staying attuned to advancements in medical research and technology will be crucial for capturing growth opportunities and sustaining a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fusidic Acid Market

The Fusidic Acid Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • The rising number of skin infection cases worldwide
    • Increased prevalence of MRSA infections especially in hospital settings
    • Ongoing R&D initiatives and research spendings in healthcare and pharmaceutical sectors
  • Market Restraints
    • The emergence of new antibiotics and alternative treatments of fusidic acid
  • Market Opportunities
    • Development of combination treatments with fusidic acid to enhance product efficacy
    • Emergence of diverse applications of fusidic acid in treating other microbial infections beyond skin conditions
  • Market Challenges
    • Surge in antibiotic-resistant strains posing a significant threat to the efficacy of fusidic acid

Porter's Five Forces: A Strategic Tool for Navigating the Fusidic Acid Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fusidic Acid Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fusidic Acid Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fusidic Acid Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fusidic Acid Market

A detailed market share analysis in the Fusidic Acid Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fusidic Acid Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fusidic Acid Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fusidic Acid Market

A strategic analysis of the Fusidic Acid Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fusidic Acid Market, highlighting leading vendors and their innovative profiles. These include A.S. Lifesciences, Abigail Healthcare Pharmaceutical, Albert David Ltd., Alvogen, Anant Pharmaceuticals Pvt. Ltd., Azelis, B Joshi Agrochem Pharma Pvt. Ltd., Easton Biopharmaceuticals, Eercros S.A., Glasier Wellness Inc., Glenmark Pharmaceuticals, Joyang Laboratories, Leo Pharma, Merck KGaA, Mylan N.V., National Analytical Corporation, Oaknet Healthcare Pvt. Ltd. by Eris Lifesciences Limited, Otto Chemie Pvt. Ltd., Taj Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., TOKU-E, Wellona Pharma, and Wuhan Dongkangyuan Technology Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Fusidic Acid Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Purity, market is studied across 97% to 99%, Above 99%, and Below 97%.
  • Based on Administration, market is studied across Intravenous, Oral, and Topical.
  • Based on End-Product, market is studied across Cream, Ointment, Suspension, and Tablets.
  • Based on Application, market is studied across Combination Therapy, Eye Infections, Skin Infections, and Systemic Infections.
  • Based on End-Use, market is studied across Healthcare Facilities and Veterinary Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. The rising number of skin infection cases worldwide
      • 5.1.1.2. Increased prevalence of MRSA infections especially in hospital settings
      • 5.1.1.3. Ongoing R&D initiatives and research spendings in healthcare and pharmaceutical sectors
    • 5.1.2. Restraints
      • 5.1.2.1. The emergence of new antibiotics and alternative treatments of fusidic acid
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of combination treatments with fusidic acid to enhance product efficacy
      • 5.1.3.2. Emergence of diverse applications of fusidic acid in treating other microbial infections beyond skin conditions
    • 5.1.4. Challenges
      • 5.1.4.1. Surge in antibiotic-resistant strains posing a significant threat to the efficacy of fusidic acid
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Administration: Significance of Intravenous administration of fusidic acid for critically ill patients
    • 5.2.2. Application: Increasing preference for fusidic acid to treat skin infections
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Fusidic Acid Market, by Purity

  • 6.1. Introduction
  • 6.2. 97% to 99%
  • 6.3. Above 99%
  • 6.4. Below 97%

7. Fusidic Acid Market, by Administration

  • 7.1. Introduction
  • 7.2. Intravenous
  • 7.3. Oral
  • 7.4. Topical

8. Fusidic Acid Market, by End-Product

  • 8.1. Introduction
  • 8.2. Cream
  • 8.3. Ointment
  • 8.4. Suspension
  • 8.5. Tablets

9. Fusidic Acid Market, by Application

  • 9.1. Introduction
  • 9.2. Combination Therapy
  • 9.3. Eye Infections
  • 9.4. Skin Infections
  • 9.5. Systemic Infections

10. Fusidic Acid Market, by End-Use

  • 10.1. Introduction
  • 10.2. Healthcare Facilities
  • 10.3. Veterinary Clinics

11. Americas Fusidic Acid Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Fusidic Acid Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Fusidic Acid Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Antibiotic Innovation Helps Fight Against Superbugs
    • 14.3.2. AMR Action Fund Invests in Swiss Antibiotic Maker
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. A.S. Lifesciences
  • 2. Abigail Healthcare Pharmaceutical
  • 3. Albert David Ltd.
  • 4. Alvogen
  • 5. Anant Pharmaceuticals Pvt. Ltd.
  • 6. Azelis
  • 7. B Joshi Agrochem Pharma Pvt. Ltd.
  • 8. Easton Biopharmaceuticals
  • 9. Eercros S.A.
  • 10. Glasier Wellness Inc.
  • 11. Glenmark Pharmaceuticals
  • 12. Joyang Laboratories
  • 13. Leo Pharma
  • 14. Merck KGaA
  • 15. Mylan N.V.
  • 16. National Analytical Corporation
  • 17. Oaknet Healthcare Pvt. Ltd. by Eris Lifesciences Limited
  • 18. Otto Chemie Pvt. Ltd.
  • 19. Taj Pharmaceuticals Ltd.
  • 20. Teva Pharmaceutical Industries Ltd.
  • 21. TOKU-E
  • 22. Wellona Pharma
  • 23. Wuhan Dongkangyuan Technology Co., Ltd.